Another recent study tailoring a combination of P. vivax CSP+TRAP vaccine has shown that a combination of VLP (PvCSP)+ viral vectors (PvTRAP) was superior in efficacy against infection to that of viral vectors expressing both antigens [22] and thus, such combination could also to be tested in the future. This evidence concerns the gene DNAJC5 and infection.